Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

JSH-23

🥰Excellent
Catalog No. T1930Cas No. 749886-87-1

JSH-23 is an NF-κB inhibitor that inhibits NF-κB transcriptional activity (IC50=7.1 μM) but does not affect IκBα degradation. JSH-23 is an antioxidant with anti-inflammatory activity.

JSH-23

JSH-23

🥰Excellent
Purity: 99.67%
Catalog No. T1930Cas No. 749886-87-1
JSH-23 is an NF-κB inhibitor that inhibits NF-κB transcriptional activity (IC50=7.1 μM) but does not affect IκBα degradation. JSH-23 is an antioxidant with anti-inflammatory activity.
Pack SizePriceAvailabilityQuantity
1 mg$36In Stock
2 mg$52In Stock
5 mg$85In Stock
10 mg$122In Stock
25 mg$197In Stock
50 mg$297In Stock
100 mg$453In Stock
1 mL x 10 mM (in DMSO)$94In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "JSH-23"

Select Batch
Purity:99.67%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
JSH-23 is an NF-κB inhibitor that inhibits NF-κB transcriptional activity (IC50=7.1 μM) but does not affect IκBα degradation. JSH-23 is an antioxidant with anti-inflammatory activity.
Targets&IC50
NF-κB:7.1 μM
In vitro
METHODS: Bone marrow macrophage BMMs were treated with JSH-23 (0.78-200 µM) for 48-96 h. Cell viability was measured by CCK-8 assay.
RESULTS: JSH-23 had no detectable toxic effects at concentrations below 50 µM. [1]
METHODS: Macrophages RAW 264.7 harboring the reporter gene pNF-κB-SEAP-NPT were treated with LPS (1 µg/mL) and JSH-23 (1-30 µM) for 16 days, and SEAP expression was assayed to reflect NF-κB transcriptional activity.
RESULTS: JSH-23 inhibited LPS-induced SEAP expression in a dose-dependent manner by 23±3% at 3 µM, 68±3% at 10 µM, and 103±4% at 30 µM. JSH-23 inhibited NF-κB transcriptional activity. [2]
In vivo
METHODS: To investigate the role in diabetic neuropathy, JSH-23 (1-3 mg/kg) was administered orally to streptozotocin-induced diabetic rats once daily for two weeks.
RESULTS: JSH-23 treatment significantly reversed nerve conduction and nerve blood flow deficits in diabetic animals. The treatment also partially corrected the reduced mechanical pain threshold.JSH-23 treatment inhibited nuclear translocation of the p65/p50 subunit in the sciatic nerve. [3]
Kinase Assay
Measurement of NF-κB transcriptional activity: Macrophages RAW 264.7 transfected stably with reporter plasmid of pNF-κB-SEAP-NPT are treated with 1 μg/ml LPS and/or sample for 16 hours. As the reporter, SEAP activity in the cell-free culture media is measured as followed. Single cell-derived stable transfectants are plated in 5 ml of T-25 flask, and the media is decanted 24 h later. At this time, cells are washed twice with phosphate-buffered saline, and incubations are initiated by addition of new media. Chemicals are added to the culture medium after 24 h of incubations. Aliquots (25 ml) of medium from a control or chemical-treated cultures are taken at 0, 3, 20, 24, 48, and 72 h, heated at 65°C for 5 min to eliminate the alkaline phosphatase activity, and used immediately or stored at -20°C. Mixtures consisting of dilution buffer (25 ml), assay buffer (97 ml), culture media (25 ml), and 4-methylumbelliferyl phosphate (MUP, 1 mM, 3 ml) in each well of the 96-well plates are incubated for 60 min in the dark at room temperature. Fluorescence emits the product of the SEAP/MUP is measured at 449 nm using a 96-well plate fluorometer after excitation at 360 nm.
Cell Research
Macrophages RAW 264.7 are incubated with various concentrations of JSH-23 compound for 24 h. The cells are treated with WST-1 solution and absorbance is measured at 450 nm.(Only for Reference)
Chemical Properties
Molecular Weight240.34
FormulaC16H20N2
Cas No.749886-87-1
SmilesCc1ccc(NCCCc2ccccc2)c(N)c1
Relative Density.1.086g/cm3
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (208.04 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 16 mg/mL (66.6 mM)
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM4.1608 mL20.8039 mL41.6077 mL208.0386 mL
5 mM0.8322 mL4.1608 mL8.3215 mL41.6077 mL
10 mM0.4161 mL2.0804 mL4.1608 mL20.8039 mL
20 mM0.2080 mL1.0402 mL2.0804 mL10.4019 mL
50 mM0.0832 mL0.4161 mL0.8322 mL4.1608 mL
DMSO
1mg5mg10mg50mg
100 mM0.0416 mL0.2080 mL0.4161 mL2.0804 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy JSH-23 | purchase JSH-23 | JSH-23 cost | order JSH-23 | JSH-23 chemical structure | JSH-23 in vivo | JSH-23 in vitro | JSH-23 formula | JSH-23 molecular weight